News
Mounajro
InnovationGLP-1 boom causing pharma players FOMOGLP-1 boom causing pharma players FOMO
Industry experts at Bio-Europe Spring congratulated Eli Lilly and Novo Nordisk for persisting in the GLP-1 space and discussed how the next wave of innovation is not always clear.
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.